| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q1 2024 | Exited | −117K | −$36M | −100.0% | 0 | May 15, 2024 |
| Q4 2023 | New | +117K | +$29M | – | 117K | Feb 14, 2024 |
| Q1 2023 | Reduced | −40K | −$10M | −21.9% | 142K | May 15, 2023 |
| Q4 2022 | Added | +108K | +$24M | +143.3% | 182K | Feb 14, 2023 |
| Q3 2022 | Unchanged | – | – | – | 75K | Nov 14, 2022 |
| Q2 2022 | New | +75K | +$16M | – | 75K | Aug 15, 2022 |
| Q3 2021 | Reduced | −18K | −$4.4M | −4.4% | 387K | Nov 15, 2021 |
| Q2 2021 | Reduced | −545K | −$111M | −57.4% | 405K | Aug 16, 2021 |
| Q1 2021 | First covered | – | – | – | 950K | May 17, 2021 |
Not currently. David Tepper fully exited HCA in Q1 2024, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
David Tepper held HCA since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Yes. David Tepper reduced and then fully exited HCA by Q1 2024; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
None as of the latest filing: David Tepper has exited HCA. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
David Tepper's estimated average buy price for HCA is $247.16, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
